FDA approves twice-yearly HIV prevention shot amid questions over cost, access
PALM SPRINGS, Calif. (KESQ) The U.S. Food and Drug Administration has approved a groundbreaking HIV prevention shot that only needs to be taken twice a year. Medical experts are calling it one of the most significant advancements in HIV prevention since the arrival of PrEP. The injectable drug, Lenacapavir, will be sold under the brand
Continue Reading